Iwatsuki K, Iijima F, Chiba S
Clin Exp Pharmacol Physiol. 1984 May-Jun;11(3):231-5. doi: 10.1111/j.1440-1681.1984.tb00260.x.
Effects of bromocriptine on the secretion of pancreatic juice were investigated with dog isolated, blood-perfused pancreas. Bromocriptine (1-10 mg) caused dose-dependent increases in the secretion of pancreatic juice. However, bromocriptine did not affect the perfusion blood flow rate. The secretory response to bromocriptine was inhibited by pretreatment with a dopamine antagonist, sulpiride, but not by phentolamine, propranolol, atropine, metiamide, indomethacin or tetrodotoxin. Bromocriptine caused a dopamine-like secretion of the pancreatic juice containing a high concentration of bicarbonate but had little effect on protein output. These results suggest that bromocriptine increases pancreatic secretion stimulating directly on pancreatic dopamine receptors.
采用犬离体血液灌注胰腺,研究了溴隐亭对胰液分泌的影响。溴隐亭(1 - 10毫克)可引起胰液分泌呈剂量依赖性增加。然而,溴隐亭并不影响灌注血流速率。用多巴胺拮抗剂舒必利预处理可抑制对溴隐亭的分泌反应,但酚妥拉明、普萘洛尔、阿托品、甲硫咪特、吲哚美辛或河豚毒素则无此作用。溴隐亭可引起含高浓度碳酸氢盐的胰液呈多巴胺样分泌,但对蛋白质分泌影响不大。这些结果表明,溴隐亭通过直接刺激胰腺多巴胺受体增加胰腺分泌。